141 related articles for article (PubMed ID: 36497142)
21. Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis.
Castañeda-Delgado J; Hernández-Pando R; Serrano CJ; Aguilar-León D; León-Contreras J; Rivas-Santiago C; Méndez R; González-Curiel I; Enciso-Moreno A; Rivas-Santiago B
Clin Exp Immunol; 2010 Sep; 161(3):542-50. PubMed ID: 20636399
[TBL] [Abstract][Full Text] [Related]
22. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
[TBL] [Abstract][Full Text] [Related]
23. LL-37 as a therapeutic target for late stage prostate cancer.
Hensel JA; Chanda D; Kumar S; Sawant A; Grizzle WE; Siegal GP; Ponnazhagan S
Prostate; 2011 May; 71(6):659-70. PubMed ID: 20957672
[TBL] [Abstract][Full Text] [Related]
24. Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells.
Suzuki K; Murakami T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
Int Immunol; 2011 Mar; 23(3):185-93. PubMed ID: 21393634
[TBL] [Abstract][Full Text] [Related]
25. Cathelicidin Related Antimicrobial Peptide (CRAMP) Enhances Bone Marrow Cell Retention and Attenuates Cardiac Dysfunction in a Mouse Model of Myocardial Infarction.
Klyachkin YM; Idris A; Rodell CB; Tripathi H; Ye S; Nagareddy P; Asfour A; Gao E; Annabathula R; Ratajczak M; Burdick JA; Abdel-Latif A
Stem Cell Rev Rep; 2018 Oct; 14(5):702-714. PubMed ID: 29948752
[TBL] [Abstract][Full Text] [Related]
26. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
Danka ES; Hunstad DA
J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
[TBL] [Abstract][Full Text] [Related]
27. Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.
Bei Y; Pan LL; Zhou Q; Zhao C; Xie Y; Wu C; Meng X; Gu H; Xu J; Zhou L; Sluijter JPG; Das S; Agerberth B; Sun J; Xiao J
BMC Med; 2019 Feb; 17(1):42. PubMed ID: 30782145
[TBL] [Abstract][Full Text] [Related]
28. Cathelicidin antimicrobial peptide expression is not induced or required for bacterial clearance during salmonella enterica infection of human monocyte-derived macrophages.
Strandberg KL; Richards SM; Gunn JS
Infect Immun; 2012 Nov; 80(11):3930-8. PubMed ID: 22927052
[TBL] [Abstract][Full Text] [Related]
29. Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia.
Kovach MA; Ballinger MN; Newstead MW; Zeng X; Bhan U; Yu FS; Moore BB; Gallo RL; Standiford TJ
J Immunol; 2012 Jul; 189(1):304-11. PubMed ID: 22634613
[TBL] [Abstract][Full Text] [Related]
30. Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation.
Jo M; Kim JH; Song GJ; Seo M; Hwang EM; Suk K
J Neurosci; 2017 Mar; 37(11):2878-2894. PubMed ID: 28193696
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD
Roboon J; Hattori T; Ishii H; Takarada-Iemata M; Nguyen DT; Heer CD; O'Meally D; Brenner C; Yamamoto Y; Okamoto H; Higashida H; Hori O
J Neurochem; 2021 Jul; 158(2):311-327. PubMed ID: 33871064
[TBL] [Abstract][Full Text] [Related]
32. Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.
Norden DM; Trojanowski PJ; Villanueva E; Navarro E; Godbout JP
Glia; 2016 Feb; 64(2):300-16. PubMed ID: 26470014
[TBL] [Abstract][Full Text] [Related]
33. Absence of in vitro innate immunomodulation by insect-derived short proline-rich antimicrobial peptides points to direct antibacterial action in vivo.
Fritsche S; Knappe D; Berthold N; von Buttlar H; Hoffmann R; Alber G
J Pept Sci; 2012 Oct; 18(10):599-608. PubMed ID: 22936623
[TBL] [Abstract][Full Text] [Related]
34. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
[TBL] [Abstract][Full Text] [Related]
35. Paroxetine suppresses reactive microglia-mediated but not lipopolysaccharide-induced inflammatory responses in primary astrocytes.
Zhang X; Zhu LB; He JH; Zhang HQ; Ji SY; Zhang CN; Hou NN; Huang CP; Zhu JH
J Neuroinflammation; 2020 Feb; 17(1):50. PubMed ID: 32024542
[TBL] [Abstract][Full Text] [Related]
36. A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli.
Welser-Alves JV; Crocker SJ; Milner R
J Neuroinflammation; 2011 Jun; 8():61. PubMed ID: 21631912
[TBL] [Abstract][Full Text] [Related]
37. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
[No Abstract] [Full Text] [Related]
38. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
[TBL] [Abstract][Full Text] [Related]
39. Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth.
Li D; Beisswenger C; Herr C; Schmid RM; Gallo RL; Han G; Zakharkina T; Bals R
Oncogene; 2014 May; 33(21):2709-16. PubMed ID: 23812430
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.
Mookherjee N; Brown KL; Bowdish DM; Doria S; Falsafi R; Hokamp K; Roche FM; Mu R; Doho GH; Pistolic J; Powers JP; Bryan J; Brinkman FS; Hancock RE
J Immunol; 2006 Feb; 176(4):2455-64. PubMed ID: 16456005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
